Immucell Corp (ICCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 10,357 | 7,626 | 5,506 | 6,445 | 8,067 |
| Cost of Goods | 5,700 | 4,716 | 3,143 | 3,627 | 4,713 |
| Gross Profit | 4,657 | 2,910 | 2,363 | 2,818 | 3,354 |
| Operating Expenses | 3,388 | 3,684 | 2,486 | 2,875 | 2,950 |
| Operating Income | 1,969 | -58 | 20 | 570 | 1,118 |
| Other Income | -15 | -2,788 | -155 | -66 | 331 |
| Pre-tax Income | 1,954 | -2,846 | -135 | 504 | 1,449 |
| Income Tax | 13 | 3 | 5 | 2 | 2 |
| Net Income Continuous | 1,942 | -2,849 | -140 | 502 | 1,447 |
| Net Income | $1,942 | $-2,849 | $-140 | $502 | $1,447 |
| EPS Basic Total Ops | 0.21 | -0.32 | -0.02 | 0.06 | 0.16 |
| EPS Basic Continuous Ops | 0.21 | -0.32 | -0.02 | 0.06 | 0.16 |
| EPS Diluted Total Ops | 0.21 | -0.32 | -0.02 | 0.06 | 0.16 |
| EPS Diluted Continuous Ops | 0.21 | -0.32 | -0.02 | 0.06 | 0.16 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.31 | -0.02 | 0.06 | 0.16 |
| EBITDA(a) | $2,501 | $652 | $729 | $1,249 | $1,804 |